{"id":36946,"date":"2026-09-07T07:22:00","date_gmt":"2026-09-07T14:22:00","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/is-zepbound-more-effective-than-wegovy-copy"},"modified":"2026-09-08T06:49:24","modified_gmt":"2026-09-08T13:49:24","slug":"how-to-switch-from-zepbound-to-wegovy","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy","title":{"rendered":"How to switch from Zepbound to Wegovy: a step-by-step guide for 2026"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Switching from Zepbound to Wegovy is a common and safe decision &#8211; but it requires medical guidance. Both are FDA-approved <\/span><a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\"><span style=\"font-weight: 400;\">GLP-1 weight loss medications<\/span><\/a><span style=\"font-weight: 400;\">, yet they work through different receptor pathways. That means the transition involves specific timing, dose adjustments, and a short period of adaptation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This guide covers why people switch, how doctors manage the process, and what to realistically expect in the first weeks on <\/span><a href=\"https:\/\/getheally.com\/patients\/wegovy\"><span style=\"font-weight: 400;\">Wegovy (semaglutide)<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2 id=\"key-takeaways\"><span style=\"font-weight: 400;\">Key takeaways<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">You can switch from <\/span><a href=\"https:\/\/getheally.com\/patients\/zepbound\"><span style=\"font-weight: 400;\">Zepbound (tirzepatide)<\/span><\/a><span style=\"font-weight: 400;\"> to Wegovy (semaglutide) under medical supervision.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Doctors typically recommend a 7-day washout period between the last Zepbound injection and the first Wegovy dose.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Most providers restart Wegovy at the lowest dose (0.25 mg) and titrate up over 16-20 weeks &#8211; even if you were on a high Zepbound dose.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In the <\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183\"><span style=\"font-weight: 400;\">SURMOUNT-5 head-to-head trial<\/span><\/a><span style=\"font-weight: 400;\">, Zepbound produced 20.2% average weight loss versus 13.7% for Wegovy 2.4 mg at 72 weeks. But individual results vary, and the newer <\/span><a href=\"https:\/\/www.drugs.com\/newdrugs\/fda-approves-novo-nordisk-s-new-wegovy-hd-delivering-highest-weight-loss-date-wegovy-6749.html\"><span style=\"font-weight: 400;\">Wegovy HD 7.2 mg<\/span><\/a><span style=\"font-weight: 400;\"> narrows that gap significantly with 20.7% mean weight loss.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Wegovy has an FDA-approved cardiovascular benefit that Zepbound does not &#8211; it reduced major cardiac events by 20% in the <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37952131\/\"><span style=\"font-weight: 400;\">SELECT trial<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gastrointestinal side effects during the switch are common but usually mild and temporary.<\/span><\/li>\n<\/ul>\n<h2 id=\"why-people-switch-from-zepbound-to-wegovy\"><span style=\"font-weight: 400;\">Why people switch from Zepbound to Wegovy<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Not every medication works the same way for every person. Switching from tirzepatide to semaglutide is a routine clinical scenario, not a sign of failure.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Here are the most common reasons patients make this change:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Insurance or coverage shifts.<\/b><span style=\"font-weight: 400;\"> Formularies change. Some plans drop <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/how-much-does-zepbound-cost\"><span style=\"font-weight: 400;\">Zepbound coverage<\/span><\/a><span style=\"font-weight: 400;\"> or add prior authorization requirements that make access harder.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Side effect tolerance.<\/b> <a href=\"https:\/\/getheally.com\/patients\/news\/how-does-zepbound-work-for-weight-loss\"><span style=\"font-weight: 400;\">Zepbound<\/span><\/a><span style=\"font-weight: 400;\"> targets two hormone receptors (GLP-1 and GIP) at once. Some patients find the dual-agonist side effects &#8211; especially nausea or GI distress &#8211; harder to manage. Switching to a single-receptor GLP-1 like <\/span><a href=\"https:\/\/getheally.com\/patients\/semaglutide\"><span style=\"font-weight: 400;\">semaglutide<\/span><\/a><span style=\"font-weight: 400;\"> sometimes produces a milder side effect profile.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Cardiovascular protection.<\/b><span style=\"font-weight: 400;\"> Wegovy is the only GLP-1 weight loss injection with an FDA-approved indication for reducing the risk of heart attack and stroke in adults with cardiovascular disease and obesity or overweight. If your doctor identifies a cardiac risk, this may tip the decision.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Cost considerations.<\/b> <a href=\"https:\/\/getheally.com\/patients\/news\/what-youll-pay-for-wegovy-with-no-insurance\"><span style=\"font-weight: 400;\">Wegovy pricing<\/span><\/a><span style=\"font-weight: 400;\"> can differ from Zepbound depending on insurance, copay programs, and pharmacy. The new <\/span><a href=\"https:\/\/getheally.com\/patients\/wegovy-pills\"><span style=\"font-weight: 400;\">Wegovy pill (oral semaglutide 25 mg)<\/span><\/a><span style=\"font-weight: 400;\"> also offers a lower-cost entry point starting at $149\/month.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Personal preference.<\/b><span style=\"font-weight: 400;\"> Some patients simply respond better to semaglutide. Individual physiology matters more than averages from clinical trials.<\/span><\/li>\n<\/ul>\n<p><b>Related reading:<\/b> <a href=\"https:\/\/getheally.com\/patients\/news\/zepbound-alternatives-comparing-access-insurance-and-effectiveness\"><span style=\"font-weight: 400;\">Zepbound alternatives: comparing access, insurance, and effectiveness<\/span><\/a><\/p>\n<h2 id=\"how-zepbound-and-wegovy-differ\"><span style=\"font-weight: 400;\">How Zepbound and Wegovy differ<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Before you switch, it helps to understand what actually changes between these two GLP-1 medications.<\/span><\/p>\n<table>\n<thead>\n<tr>\n<th><b>Feature<\/b><\/th>\n<th><b>Zepbound (tirzepatide)<\/b><\/th>\n<th><b>Wegovy (semaglutide)<\/b><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">Mechanism<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Dual GIP\/GLP-1 receptor agonist<\/span><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 receptor agonist<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Manufacturer<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Eli Lilly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Novo Nordisk<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Dosing frequency<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Once weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Once weekly (injection) or once daily (pill)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Max injection dose<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15 mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">7.2 mg (Wegovy HD, approved March 2026)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Avg weight loss (SURMOUNT-5)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20.2% at 72 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">13.7% at 72 weeks (2.4 mg)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Avg weight loss (STEP UP)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">&#8211;<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20.7% at 72 weeks (7.2 mg)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">FDA cardiovascular indication<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Yes (SELECT trial)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Oral option available<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Yes (25 mg tablet, approved Dec 2025)<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">The biggest clinical difference: Zepbound activates two incretin hormone receptors, while Wegovy activates one. Both slow gastric emptying, reduce appetite, and support weight loss &#8211; but through slightly different pathways.<\/span><\/p>\n<p><b>Explore options:<\/b> <a href=\"https:\/\/getheally.com\/patients\/news\/wegovy-pills-vs-injection\"><span style=\"font-weight: 400;\">Semaglutide vs tirzepatide &#8211; which is right for you?<\/span><\/a><\/p>\n<h2 id=\"how-doctors-manage-the-zepbound-to-wegovy-transition\"><span style=\"font-weight: 400;\">How doctors manage the Zepbound to Wegovy transition<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">This is not something to do on your own. A licensed physician should guide every step of the switch.<\/span><\/p>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Step 1: Stop Zepbound.<\/b><span style=\"font-weight: 400;\"> Your doctor will tell you when to take your final tirzepatide injection. Most providers recommend a 7-day washout period before starting the new medication.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Step 2: Start Wegovy at the lowest dose.<\/b><span style=\"font-weight: 400;\"> Even if you tolerated Zepbound 15 mg, doctors typically restart Wegovy at 0.25 mg weekly. This conservative approach minimizes gastrointestinal side effects and lets your body adjust to semaglutide.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Step 3: Titrate up gradually.<\/b><span style=\"font-weight: 400;\"> Wegovy follows a standard dose escalation schedule &#8211; increasing every 4 weeks through 0.5 mg, 1 mg, 1.7 mg, and finally the 2.4 mg maintenance dose. If your provider prescribes <\/span><a href=\"https:\/\/www.prnewswire.com\/news-releases\/fda-approves-novo-nordisks-new-wegovy-hd-injection-delivering-the-highest-weight-loss-to-date-for-a-wegovy-injection-adding-to-its-already-expansive-clinical-profile-302718982.html\"><span style=\"font-weight: 400;\">Wegovy HD<\/span><\/a><span style=\"font-weight: 400;\">, you may later step up to 7.2 mg.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Step 4: Monitor and adjust.<\/b><span style=\"font-weight: 400;\"> Your doctor tracks side effects, appetite changes, and weight trends throughout the transition. Some patients move through escalation faster; others need more time at each step.<\/span><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">You can <\/span><a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\"><span style=\"font-weight: 400;\">book a consultation with a Heally physician<\/span><\/a><span style=\"font-weight: 400;\"> to discuss switching and get a personalized transition plan.<\/span><\/p>\n<h2 id=\"what-to-expect-in-the-first-weeks-after-switching\"><span style=\"font-weight: 400;\">What to expect in the first weeks after switching<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The transition period can feel a bit bumpy. Here is what most patients report:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Appetite fluctuations.<\/b><span style=\"font-weight: 400;\"> You may notice reduced appetite control during the initial lower Wegovy doses. This usually improves as the dose increases toward maintenance levels.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>GI side effects.<\/b><span style=\"font-weight: 400;\"> Nausea, mild diarrhea, or constipation can return during the switch. These are typical with any GLP-1 medication change and generally settle within 2-4 weeks.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Temporary weight plateau.<\/b><span style=\"font-weight: 400;\"> Starting at a lower dose means the weight loss effect may pause briefly. This is normal &#8211; not a reason to worry. Weight loss typically resumes once you reach the therapeutic dose range.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Subtle differences in how fullness feels.<\/b><span style=\"font-weight: 400;\"> Because tirzepatide and semaglutide activate different receptor combinations, the quality of satiety can feel slightly different. Some patients describe Wegovy&#8217;s appetite suppression as steadier but less intense.<\/span><\/li>\n<\/ul>\n<h3 id=\"when-to-call-your-doctor\"><span style=\"font-weight: 400;\">When to call your doctor<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Mild nausea is expected. But contact your healthcare provider if you experience severe vomiting, inability to eat or drink for more than 24 hours, significant abdominal pain, or signs of dehydration.<\/span><\/p>\n<h2 id=\"common-mistakes-when-switching-glp-1-medications\"><span style=\"font-weight: 400;\">Common mistakes when switching GLP-1 medications<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Rushing the dose escalation.<\/b><span style=\"font-weight: 400;\"> Starting Wegovy at a higher dose to &#8220;match&#8221; your Zepbound level often backfires. It leads to worse side effects without faster results. Follow the gradual schedule.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Expecting identical outcomes.<\/b><span style=\"font-weight: 400;\"> Zepbound and Wegovy are different drugs. Your weight loss rate, appetite effects, and side effect profile may not be the same &#8211; and that is okay.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Dropping healthy habits.<\/b><span style=\"font-weight: 400;\"> Medication changes are not a reason to stop eating well, moving your body, or sleeping enough. Lifestyle factors still account for a meaningful share of your results.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Skipping follow-up appointments.<\/b><span style=\"font-weight: 400;\"> Your doctor needs to assess how semaglutide works for you specifically. Do not skip check-ins during the transition period.<\/span><\/li>\n<\/ul>\n<p><b><i>Also useful:<\/i><\/b> <a href=\"https:\/\/getheally.com\/patients\/news\/how-does-wegovy-help-you-lose-weight\"><i><span style=\"font-weight: 400;\">How does Wegovy help you lose weight?<\/span><\/i><\/a><\/p>\n<h2 id=\"wegovy-options-in-2026-injection-and-pill\"><span style=\"font-weight: 400;\">Wegovy options in 2026: injection and pill<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">One advantage of switching to semaglutide in 2026: you now have more options than ever.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Wegovy injection 2.4 mg<\/b><span style=\"font-weight: 400;\"> &#8211; the established weekly shot, with the largest real-world evidence base among GLP-1 weight loss medications.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916516\"><b>Wegovy HD injection 7.2 mg<\/b><\/a><span style=\"font-weight: 400;\"> &#8211; FDA-approved March 2026 for patients who tolerate 2.4 mg and need additional weight reduction. Demonstrated 20.7% mean weight loss in the STEP UP trial.<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/getheally.com\/patients\/wegovy-pills\"><b>Wegovy pill (oral semaglutide 25 mg)<\/b><\/a><span style=\"font-weight: 400;\"> &#8211; FDA-approved December 2025. A daily tablet that delivers comparable weight loss without needles or refrigeration. <\/span><a href=\"https:\/\/getheally.com\/patients\/news\/wegovy-pills-vs-injection\"><span style=\"font-weight: 400;\">Compare Wegovy pills vs injection here<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Your doctor can help determine which Wegovy form fits your lifestyle, tolerance, and treatment goals. If you prefer an oral GLP-1 option, the <\/span><a href=\"https:\/\/getheally.com\/patients\/wegovy-pills\"><span style=\"font-weight: 400;\">Wegovy pill<\/span><\/a><span style=\"font-weight: 400;\"> removes the injection barrier entirely.<\/span><\/p>\n<p><b><i>Explore more treatments:<\/i><\/b> <a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\"><i><span style=\"font-weight: 400;\">All weight loss prescription options at Heally<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> | <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/ozempic\"><i><span style=\"font-weight: 400;\">Ozempic<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> | <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/mounjaro\"><i><span style=\"font-weight: 400;\">Mounjaro<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> | <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/tirzepatide\"><i><span style=\"font-weight: 400;\">Tirzepatide<\/span><\/i><\/a><\/p>\n<h2 id=\"the-bottom-line\"><span style=\"font-weight: 400;\">The bottom line<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Switching from Zepbound to Wegovy is a straightforward process when a doctor guides it. The transition involves a short washout, a fresh dose escalation, and a few weeks of adjustment. For many patients, Wegovy offers unique advantages &#8211; including a proven cardiovascular benefit, a new high-dose 7.2 mg option, and the first oral GLP-1 pill approved for weight loss.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">What matters most is working with a provider who knows your history and can tailor the switch to your body.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">If you are considering a switch, <\/span><\/i><a href=\"https:\/\/getheally.com\/patients\/weight-loss-prescription\"><i><span style=\"font-weight: 400;\">talk to a licensed Heally physician today<\/span><\/i><\/a><i><span style=\"font-weight: 400;\">. Same-day online consultations are available, and prescriptions ship to your door within 24-48 hours.<\/span><\/i><\/p>\n<h2 id=\"faq\"><span style=\"font-weight: 400;\">FAQ<\/span><\/h2>\n<p><b>Can I switch from Zepbound to Wegovy mid-treatment?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Yes. You can switch from Zepbound (tirzepatide) to Wegovy (semaglutide) at any point during treatment. Your doctor will plan the timing around your last Zepbound dose and recommend a washout period &#8211; usually about 7 days &#8211; before starting Wegovy.<\/span><\/p>\n<p><b>Will I gain weight when switching from Zepbound to Wegovy?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Some patients experience a brief weight plateau during the lower starting doses of Wegovy. Significant weight gain is uncommon if you maintain healthy eating habits and follow your doctor&#8217;s escalation plan. Weight loss typically resumes at therapeutic doses.<\/span><\/p>\n<p><b>Is Wegovy less effective than Zepbound for weight loss?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">In the SURMOUNT-5 trial, Zepbound (tirzepatide) produced greater average weight loss than Wegovy 2.4 mg (semaglutide) &#8211; 20.2% versus 13.7% at 72 weeks. However, the newer Wegovy HD 7.2 mg dose showed 20.7% mean weight loss in the STEP UP trial, which is comparable. Individual responses vary significantly between patients.<\/span><\/p>\n<p><b>What is the recommended starting dose of Wegovy after Zepbound?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Most doctors start Wegovy at 0.25 mg weekly, regardless of your previous Zepbound dose. The standard escalation increases the dose every 4 weeks until you reach the 2.4 mg maintenance dose. Patients who tolerate 2.4 mg well may later step up to Wegovy HD 7.2 mg.<\/span><\/p>\n<p><b>Does Wegovy have benefits that Zepbound does not?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Yes. Wegovy is the only GLP-1 weight loss medication with an FDA-approved cardiovascular benefit. In the SELECT trial, semaglutide reduced the risk of major adverse cardiovascular events by 20% compared to placebo. Wegovy also offers an oral pill form &#8211; the Wegovy pill (semaglutide 25 mg), approved in December 2025.<\/span><\/p>\n<p><b>Can I switch from Zepbound to the Wegovy pill instead of the injection?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Yes. If you prefer to avoid injections, you can transition from Zepbound directly to oral Wegovy (semaglutide 25 mg) after an appropriate washout period. The Wegovy pill must be taken daily on an empty stomach with a 30-minute fast before eating. Discuss this option with your prescriber.<\/span><\/p>\n<h2 id=\"sources\"><span style=\"font-weight: 400;\">Sources<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Eli Lilly. Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine. May 11, 2025. <\/span><a href=\"https:\/\/investor.lilly.com\"><span style=\"font-weight: 400;\">https:\/\/investor.lilly.com<\/span><\/a><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Novo Nordisk. FDA approves Wegovy HD (semaglutide 7.2 mg), providing 20.7% mean weight loss. March 19, 2026. <\/span><a href=\"https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916516\"><span style=\"font-weight: 400;\">https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916516<\/span><\/a><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37952131\/\"><span style=\"font-weight: 400;\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37952131\/<\/span><\/a><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Novo Nordisk. FDA approves Wegovy pill (oral semaglutide 25 mg) for weight loss in adults. December 2025. <\/span><a href=\"https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916472\"><span style=\"font-weight: 400;\">https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=916472<\/span><\/a><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2026. <\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215256s024lbl.pdf\"><span style=\"font-weight: 400;\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215256s024lbl.pdf<\/span><\/a><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">GoodRx. Zepbound vs. Wegovy for weight loss: 6 differences to consider. <\/span><a href=\"https:\/\/www.goodrx.com\/conditions\/weight-loss\/zepbound-vs-wegovy\"><span style=\"font-weight: 400;\">https:\/\/www.goodrx.com\/conditions\/weight-loss\/zepbound-vs-wegovy<\/span><\/a><\/li>\n<\/ul>\n<h2 id=\"medical-disclaimer\"><i><span style=\"font-weight: 400;\">Medical disclaimer<\/span><\/i><\/h2>\n<p><i><span style=\"font-weight: 400;\">This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or switching any prescription medication. Individual results vary.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"Switching from Zepbound to Wegovy is a common and safe decision &#8211; but it requires medical guidance. Both&hellip;\n","protected":false},"author":10,"featured_media":36952,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1838,1829,1844,1794,1834],"tags":[2279,2278,1793,1801,1840,1832],"class_list":{"0":"post-36946","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-semaglutide-weight-loss","8":"category-tirzepatide","9":"category-wegovy","10":"category-weight-loss","11":"category-zepbound","12":"tag-dosing","13":"tag-medication-comparison","14":"tag-semaglutide","15":"tag-wegovy","16":"tag-weight-loss-results","17":"tag-zepbound"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How to switch from Zepbound to Wegovy - Heally<\/title>\n<meta name=\"description\" content=\"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to switch from Zepbound to Wegovy - Heally\" \/>\n<meta property=\"og:description\" content=\"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-07T14:22:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T13:49:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ben Krasne MD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ben Krasne MD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\"},\"author\":{\"name\":\"Ben Krasne MD\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\"},\"headline\":\"How to switch from Zepbound to Wegovy: a step-by-step guide for 2026\",\"datePublished\":\"2026-09-07T14:22:00+00:00\",\"dateModified\":\"2026-09-08T13:49:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\"},\"wordCount\":1758,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg\",\"keywords\":[\"Dosing\",\"Medication Comparison\",\"semaglutide\",\"wegovy\",\"Weight loss results\",\"zepbound\"],\"articleSection\":[\"Semaglutide\",\"Tirzepatide\",\"Wegovy\",\"Weight Loss\",\"Zepbound\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\",\"url\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\",\"name\":\"How to switch from Zepbound to Wegovy - Heally\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg\",\"datePublished\":\"2026-09-07T14:22:00+00:00\",\"dateModified\":\"2026-09-08T13:49:24+00:00\",\"description\":\"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Woman looking at different medication. Debating switching from Zepbound to Wegovy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to switch from Zepbound to Wegovy: a step-by-step guide for 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211\",\"name\":\"Ben Krasne MD\",\"description\":\"Dr. Benjamin Krasne is a board-certified anesthesiologist. After attending the University of Florida, Dr. Ben matriculated to the University of Miami Miller School of Medicine. Dr. Krasne completed his residency at Jackson Memorial Hospital in 2017. Since graduating residency Dr. Krasne has worked throughout the United States as a traveling anesthesiologist while providing remote driven out-patient clinical services as well.\",\"sameAs\":[\"https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How to switch from Zepbound to Wegovy - Heally","description":"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy","og_locale":"en_US","og_type":"article","og_title":"How to switch from Zepbound to Wegovy - Heally","og_description":"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.","og_url":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2026-09-07T14:22:00+00:00","article_modified_time":"2026-09-08T13:49:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg","type":"image\/jpeg"}],"author":"Ben Krasne MD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ben Krasne MD","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy"},"author":{"name":"Ben Krasne MD","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211"},"headline":"How to switch from Zepbound to Wegovy: a step-by-step guide for 2026","datePublished":"2026-09-07T14:22:00+00:00","dateModified":"2026-09-08T13:49:24+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy"},"wordCount":1758,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg","keywords":["Dosing","Medication Comparison","semaglutide","wegovy","Weight loss results","zepbound"],"articleSection":["Semaglutide","Tirzepatide","Wegovy","Weight Loss","Zepbound"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy","url":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy","name":"How to switch from Zepbound to Wegovy - Heally","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg","datePublished":"2026-09-07T14:22:00+00:00","dateModified":"2026-09-08T13:49:24+00:00","description":"Learn how to safely switch from Zepbound to Wegovy. Understand timing, dosing, side effects, and what to expect during the transition.","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2026\/02\/zepbound_wegovy_switch.jpg","width":1000,"height":667,"caption":"Woman looking at different medication. Debating switching from Zepbound to Wegovy"},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/how-to-switch-from-zepbound-to-wegovy#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"How to switch from Zepbound to Wegovy: a step-by-step guide for 2026"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2019\/05\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/133ab039fcce2b4f2ef87ae214ab9211","name":"Ben Krasne MD","description":"Dr. Benjamin Krasne is a board-certified anesthesiologist. After attending the University of Florida, Dr. Ben matriculated to the University of Miami Miller School of Medicine. Dr. Krasne completed his residency at Jackson Memorial Hospital in 2017. Since graduating residency Dr. Krasne has worked throughout the United States as a traveling anesthesiologist while providing remote driven out-patient clinical services as well.","sameAs":["https:\/\/www.parkwayrestorativedentistry.com\/dr-benjamin-krasne"]}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=36946"}],"version-history":[{"count":6,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36946\/revisions"}],"predecessor-version":[{"id":37846,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36946\/revisions\/37846"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/36952"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=36946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=36946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=36946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}